Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

New York Oncology Hematology | Researchclopedia

Back to institutions

New York Oncology Hematology

New York, New Yorkhealthcare

660

Works

53,102

Citations

103

h-index

Top Research Topics

Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics Cancer Immunotherapy and Biomarkers

Top Researchers

Marc Ladanyi Memorial Sloan Kettering Cancer Center

2,492 works208,492 citationsh-index: 204

Recent Research

Epigenetic remodeling in sarcoma promotes T-cell infiltration via modulation of the Hippo pathway

Mireia Cruz De los Santos,Yi Chen,et al.

20260 citations

Colorectal Cancer Treatments and Studies

Lymphoma Diagnosis and Treatment

Cancer Treatment and Pharmacology

HER2/EGFR in Cancer Research

CAR-T cell therapy research

Breast Cancer Treatment Studies

Chronic Lymphocytic Leukemia Research

Multiple Myeloma Research and Treatments

Pancreatic and Hepatic Oncology Research

Nikolaus Schultz Memorial Sloan Kettering Cancer Center

1,817 works207,515 citationsh-index: 162

Jedd D. Wolchok Cornell University

1,393 works204,852 citationsh-index: 173

Drew M. Pardoll Bloomberg (United States)

889 works165,794 citationsh-index: 164

Johann S. de Bono Royal Marsden NHS Foundation Trust

2,486 works134,651 citationsh-index: 160

Howard I. Scher Memorial Sloan Kettering Cancer Center

1,421 works132,289 citationsh-index: 164

Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real‐world analysis from 20 US centers

Allison M. Bock,Peirong Hao,et al.

20260 citations

Analysis of Clinical Benefit Using DNG64- <i>CAR-V</i> Chimeric Tumor Targeted Amphotropic RNA Vector in <i>CCNG1</i> Expressing Cancers

Sant P. Chawla,Samantha Jeffrey,et al.

20260 citations

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced <i>RET</i> Fusion–Positive Non–Small Cell Lung Cancer

Benjamin Besse,Vivek Subbiah,et al.

20260 citations

140TiP KANDLELIT-007: Phase III, open-label study of first-line calderasib with subcutaneous pembrolizumab (pembro SC) vs pembro SC plus chemotherapy (chemo) for KRAS G12C– mutant advanced/metastatic nonsquamous NSCLC

M. Provencio Pulla,M.J. Hochmair,et al.

20260 citations

Biomarker analysis from the phase 2 LITESPARK-013 study of 2 different belzutifan (bel) doses in participants (pts) with advanced clear cell renal cell carcinoma (ccRCC).

Neeraj Agarwal,James Brugarolas,et al.

20260 citations